Learn about support and programs that may help you pay for GILOTRIF.

Learn how NSCLC is treated

The non-small cell lung cancer (NSCLC) treatment option your doctor chooses will depend on the characteristics of your lung cancer. This is one of the reasons doctors will take a sample, or biopsy, of the tumor. In addition to telling them what type of cancer you have, it also tells them if you have a specific genetic mutation. This information can help determine your treatment plan.

Today there are therapies available that block the signaling associated with specific genetic mutations in NSCLC that can cause cancer to grow and spread. Some of these genetic mutations involve epidermal growth factor receptor (EGFR), a molecule that is found in cancer and normal cells.

WHAT IS GILOTRIF?

GILOTRIF is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that:

• has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you.

• has spread to other parts of the body (metastatic), and

• has not been previously treated for metastatic lung cancer

It is not known if GILOTRIF is safe and effective in treating people with lung cancer that has resistant abnormal EGFR genes.

or

is used to treat people with squamous cell lung cancer that:

• has spread to other parts of the body, and

• has been previously treated with chemotherapy that contains platinum.


It is not known if GILOTRIF is safe and effective in children.